COVID-19 Small Molecule Therapeutics for PrEP COVID-19 Small Molecule Therapeutics for PrEP Awards Kathryn.Stokes@ati.org2025-03-10T10:52:04-04:00 Learn More
NextGen Vaccines: Immune Assays NextGen Vaccines: Immune Assays Awards Kathryn.Stokes@ati.org2025-01-07T14:09:53-05:00 Learn More
Biothreat Diagnostic Rapid Response Biothreat Diagnostic Rapid Response Awards tyler.bulin@ATI.ORG2025-04-07T09:23:21-04:00 Learn More
Enabling Technology – Decentralized Clinical Trial – Retail/Pharmacy Focus Enabling Technology – Decentralized Clinical Trial – Retail/Pharmacy Focus Awards tyler.bulin@ATI.ORG2025-03-10T10:50:34-04:00 Learn More
NextGen Vaccines: Statistical Support, Correlates of Protection, and Meta-analysis: Modules 1 & 2 NextGen Vaccines: Statistical Support, Correlates of Protection, and Meta-analysis: Modules 1 & 2 Awards tyler.bulin@ATI.ORG2024-07-23T11:39:38-04:00 Learn More
Accelerating Near-Term Availability of mRNA-based Pandemic Influenza Vaccine Accelerating Near-Term Availability of mRNA-based Pandemic Influenza Vaccine Awards tyler.bulin@ATI.ORG2024-07-19T14:29:14-04:00 Learn More
Enabling Technology – Decentralized Clinical Trial – Home Focus Enabling Technology – Decentralized Clinical Trial – Home Focus Awards tyler.bulin@ATI.ORG2024-06-19T12:43:43-04:00 Learn More
Next Gen Vaccinations: Phase 2b Clinical Trial Execution Next Gen Vaccinations: Phase 2b Clinical Trial Execution Awards Tara.Baron@ati.org2025-03-10T10:49:52-04:00 Learn More